In conclusion, we report that in an experimental model of MS, a human GFAP driven conditional TSPO KO shows a decrease in the severity of the clinical scoring and in the mRNA levels of the cytokines TNFα and CXCL10 in the spinal cord. This evidence concerns the gene CXCL10 and myeloid sarcoma.